BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11960343)

  • 1. Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission.
    Oudat R; Keating MJ; Lerner S; O'Brien S; Albitar M
    Leukemia; 2002 Apr; 16(4):632-5. PubMed ID: 11960343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
    Aymard B; Beghoura R; Molina TJ
    Nephrol Ther; 2011 Nov; 7(6):479-87. PubMed ID: 21439927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
    Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
    J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fludarabine treatment of chronic lymphoid leukemia].
    Gabeeva NG; Pivnik AV; Moiseeva TN; Zybunova EE; Samoĭlova RS; Kremenetskaia AM; Varlamova EIu; Kaplanskaia IB
    Ter Arkh; 2000; 72(8):42-5. PubMed ID: 11019427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
    Keating MJ; O'Brien S; Albitar M; Lerner S; Plunkett W; Giles F; Andreeff M; Cortes J; Faderl S; Thomas D; Koller C; Wierda W; Detry MA; Lynn A; Kantarjian H
    J Clin Oncol; 2005 Jun; 23(18):4079-88. PubMed ID: 15767648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic lymphatic leukemia].
    Lechner K; Bilbeisi S; Wittmann E; Wilfing A
    Wien Klin Wochenschr; 1994; 106(10):291-9. PubMed ID: 8053196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
    Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A;
    Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
    Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow biopsy in non-Hodgkin's lymphomas, chronic lymphoid leukemia and mycosis fungoides. 1. Incidence and infiltration patterns].
    Silva MR; Mieza MA; Saad FA; Kerbauy J; Burnier Júnior MN
    Rev Paul Med; 1990; 108(3):117-24. PubMed ID: 2287861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
    Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
    Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
    Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.